Veeva Systems
VEEV · NYSE
Bulios Fair Price
$157.45
40.6% downside
Current Price
$264.97
According to Bulios Fair Price, VEEV is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
Veeva Systems Inc. (VEEV) is an American software company specializing in providing cloud-based solutions for the pharmaceutical and biotechnology industries. The company offers integrated platforms for data management, clinical trials, marketing, and collaboration, which help pharmaceutical firms and research institutions improve efficiency and productivity in their processes. With its specialized focus and a wide range of services, Veeva Systems has gained a strong market position and is a preferred partner in the biotechnology sector. Investing in shares of Veeva Systems Inc. (VEEV) can present an interesting opportunity for investors seeking an innovative technology company with a significant presence in the pharmaceutical software domain.
Sector
Technology
Industry
Software - Application
CEO
Peter Gassner
Employees
7,928
Headquarters
Pleasanton
Upcoming events
Earnings
Upcoming earnings report